Return On Assets of CANNAPHARMARX, INC. from 30 Jun 2012 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
CANNAPHARMARX, INC. quarterly and annual Return On Assets in % history and change rate from 30 Jun 2012 to 30 Sep 2025.
  • CANNAPHARMARX, INC. Return On Assets for the quarter ending 30 Sep 2025 was -65%.
  • CANNAPHARMARX, INC. annual Return On Assets for 2023 was 54%.
  • CANNAPHARMARX, INC. annual Return On Assets for 2022 was -152%, a 6.4% decline from 2021.
  • CANNAPHARMARX, INC. annual Return On Assets for 2021 was -143%, a 2.3% increase from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

CANNAPHARMARX, INC. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -65% 01 Jul 2025 30 Sep 2025
Q2 2025 -50% 01 Apr 2025 30 Jun 2025
Q1 2024 -79% +65% +45% 01 Jan 2024 31 Mar 2024
Q4 2023 54% +205% 01 Oct 2023 31 Dec 2023
Q3 2023 -142% +142% +50% 01 Jul 2023 30 Sep 2023
Q2 2023 -154% +100% +39% 01 Apr 2023 30 Jun 2023
Q1 2023 -144% +77% +35% 01 Jan 2023 31 Mar 2023
Q4 2022 -152% -9.1% -6.4% 01 Oct 2022 31 Dec 2022
Q3 2022 -284% -128% -82% 01 Jul 2022 30 Sep 2022
Q2 2022 -254% -117% -85% 01 Apr 2022 30 Jun 2022
Q1 2022 -221% -105% -91% 01 Jan 2022 31 Mar 2022
Q4 2021 -143% +3.3% +2.3% 01 Oct 2021 31 Dec 2021
Q3 2021 -156% -42% -37% 01 Jul 2021 30 Sep 2021
Q2 2021 -137% +6.4% +4.5% 01 Apr 2021 30 Jun 2021
Q1 2021 -116% +14% +11% 01 Jan 2021 31 Mar 2021
Q4 2020 -146% -44% -44% 01 Oct 2020 31 Dec 2020
Q3 2020 -114% -44% -63% 01 Jul 2020 30 Sep 2020
Q2 2020 -143% -107% -292% 01 Apr 2020 30 Jun 2020
Q1 2020 -130% -77% -148% 01 Jan 2020 31 Mar 2020
Q4 2019 -102% +12% +11% 01 Oct 2019 31 Dec 2019
Q3 2019 -70% +493% +88% 01 Jul 2019 30 Sep 2019
Q2 2019 -37% +53% +59% 01 Apr 2019 30 Jun 2019
Q1 2019 -52% 01 Jan 2019 31 Mar 2019
Q4 2018 -114% 01 Oct 2018 31 Dec 2018
Q3 2018 -563% -537% -2066% 01 Jul 2018 30 Sep 2018
Q2 2018 -89% -56% -171% 01 Apr 2018 30 Jun 2018
Q3 2017 -26% +47011% +100% 01 Jul 2017 30 Sep 2017
Q2 2017 -33% +7556% +100% 01 Apr 2017 30 Jun 2017
Q1 2017 -73% +2903% +98% 01 Jan 2017 31 Mar 2017
Q4 2016 -236% +1317% +85% 01 Oct 2016 31 Dec 2016
Q3 2016 -47037% -46138% -5132% 01 Jul 2016 30 Sep 2016
Q2 2016 -7589% -7036% -1274% 01 Apr 2016 30 Jun 2016
Q1 2016 -2976% -2689% -938% 01 Jan 2016 31 Mar 2016
Q4 2015 -1553% 01 Oct 2015 31 Dec 2015
Q3 2015 -899% 01 Jul 2015 30 Sep 2015
Q2 2015 -552% 01 Apr 2015 30 Jun 2015
Q1 2015 -287% 01 Jan 2015 31 Mar 2015
Q2 2013 -364624% +148051% +29% 01 Apr 2013 30 Jun 2013
Q1 2013 -340148% 01 Jan 2013 31 Mar 2013
Q4 2012 -392268% 01 Oct 2012 31 Dec 2012
Q3 2012 -397076% 01 Jul 2012 30 Sep 2012
Q2 2012 -512675% 01 Apr 2012 30 Jun 2012

CANNAPHARMARX, INC. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2023 54% +205% 01 Jan 2023 31 Dec 2023
2022 -152% -9.1% -6.4% 01 Jan 2022 31 Dec 2022
2021 -143% +3.3% +2.3% 01 Jan 2021 31 Dec 2021
2020 -146% -44% -44% 01 Jan 2020 31 Dec 2020
2019 -102% +12% +11% 01 Jan 2019 31 Dec 2019
2018 -114% 01 Jan 2018 31 Dec 2018
2016 -236% +1317% +85% 01 Jan 2016 31 Dec 2016
2015 -1553% 01 Jan 2015 31 Dec 2015
2012 -392268% 01 Jan 2012 31 Dec 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.